Proteomic analysis of vascular smooth muscle cells in physiological condition and in pulmonary arterial hypertension: Toward contractile versus synthetic phenotypes

Proteomics

Volumn 16, Issue 20, 2016, Pages 2637-2649

  Régent, Alexis ^a,b   Ly, Kim Heang ^c   Lofek, Sébastien ^a   Clary, Guilhem ^a,d   Tamby, Mathieu ^a   Tamas, Nicolas ^a   Federici, Christian ^a,d   Broussard, Cédric ^a,d   Chafey, Philippe ^a,d   Liaudet Coopman, Emmanuelle ^e   Humbert, Marc ^f,g,h   Perros, Frédéric ^f,g,h   Mouthon, Luc ^a,b  

^a INSTITUT COCHIN   (France)

^b Assistance Publique Hôpitaux de Paris ^*  (France)

^c DUPUYTREN UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIV MONTPELLIER   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g Universite Paris Sud   (France)

^h CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Cell biology; ELAVL1; Paxillin; Pulmonary hypertension; Vascular smooth muscle cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANKYRIN; CALDESMON; CALPONIN; CATHEPSIN D; ELAV LIKE PROTEIN 1; MYOSIN; MYOSIN HEAVY CHAIN; PAXILLIN; PROTEIN DISULFIDE ISOMERASE 1; PROTEIN S 100; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

AORTIC SMOOTH MUSCLE CELL; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; EXTRACELLULAR SPACE; FUNCTIONAL PROTEOMICS; GENETIC TRANSFECTION; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; PULMONARY ARTERY; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; UMBILICAL ARTERY; VASCULAR SMOOTH MUSCLE CELL;

EID: 84991256115     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500006     Document Type: Article

References (34)

1. Owens, G. K., Kumar, M. S., Wamhoff, B. R., Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84, 767–801.
2. Rensen, S. S. M., Doevendans, P. A. F. M., van Eys, G. J. J. M., Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. Mon. J. Neth. Soc. Cardiol. Neth. Heart Found. 2007, 15, 100–108.
3. Ailawadi, G., Moehle, C. W., Pei, H., Walton, S. P. et al., Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J. Thorac. Cardiovasc. Surg. 2009, 138, 1392–1399.
4. Zhang, J., Wang, L., Fu, W., Wang, C. et al., Smooth muscle cell phenotypic diversity between dissected and unaffected thoracic aortic media. J. Cardiovasc. Surg. (Torino) 2013, 54, 511–521.
5. Werth, D., Grassi, G., Konjer, N., Dapas, B. et al., Proliferation of human primary vascular smooth muscle cells depends on serum response factor. Eur. J. Cell Biol. 2010, 89, 216–224.
6. Liu, R., Leslie, K. L., Martin, K. A., Epigenetic regulation of smooth muscle cell plasticity. Biochim. Biophys. Acta 2015, 1849, 448–453.
7. Madrigal-Matute, J., Rotllan, N., Aranda, J. F., Fernández-Hernando, C., MicroRNAs and atherosclerosis. Curr. Atheroscler. Rep. 2013, 15, 322, 1–13.
8. Lacolley, P., Regnault, V., Nicoletti, A., Li, Z., Michel, J.-B., The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc. Res. 2012, 95, 194–204.
9. Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R. et al., Definitions and diagnosis of pulmonary hypertension. J. Am. Coll. Cardiol. 2013, 62, D42–D50.
10. Rabinovitch, M., Molecular pathogenesis of pulmonary arterial hypertension. J. Clin. Invest. 2012, 122, 4306–4313.
11. Choi, H. Y., Rahmani, M., Wong, B. W., Allahverdian, S. et al., ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Circulation 2009, 119, 3223–3231.
12. VanderLaan, P. A., Reardon, C. A., Getz, G. S., Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 12–22.
13. Dinardo, C. L., Venturini, G., Zhou, E. H., Watanabe, I. S. et al., Variation of mechanical properties and quantitative proteomics of VSMC along the arterial tree. Am. J. Physiol. Heart Circ. Physiol. 2014, 306, H505–H516.
14. Bussone, G., Tamby, M. C., Calzas, C., Kherbeck, N. et al., IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction. Ann. Rheum. Dis. 2012, 71, 596–605.
15. Dib, H., Chafey, P., Clary, G., Federici, C. et al., Proteomes of umbilical vein and microvascular endothelial cells reflect distinct biological properties and influence immune recognition. Proteomics 2012, 12, 2547–2555.
16. Jobson, J., Applied Multivariate Data Analysis, Vol. 2, Springer, New York, 1992.
17. Umahara, T., Uchihara, T., Koyama, S., Hashimoto, T. et al., Isoform-specific immunolocalization of 14-3-3 proteins in atherosclerotic lesions of human carotid and main cerebral arteries. J. Neurol. Sci. 2012, 317, 106–111.
18. Autieri, M. V., Inducible expression of the signal transduction protein 14-3-3gamma in injured arteries and stimulated human vascular smooth muscle cells. Exp. Mol. Pathol. 2004, 76, 99–107.
19. Autieri, M. V., Carbone, C. J., 14-3-3Gamma interacts with and is phosphorylated by multiple protein kinase C isoforms in PDGF-stimulated human vascular smooth muscle cells. DNA Cell Biol. 1999, 18, 555–564.
20. de la Cuesta, F., Zubiri, I., Maroto, A. S., Posada, M. et al., Deregulation of smooth muscle cell cytoskeleton within the human atherosclerotic coronary media layer. J. Proteomics 2013, 82, 155–165.
21. Jalali, S., Ramanathan, G. K., Parthasarathy, P. T., Aljubran, S. et al., Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation. PloS One 2012, 7, e46808.
22. Yi, B., Cui, J., Ning, J., Wang, G. et al., Over-expression of PKGIα inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling. Gene 2012, 492, 354–360.
23. Moravcikova, E., Krepela, E., Prochazka, J., Rousalova, I. et al., Down-regulated expression of apoptosis-associated genes APIP and UACA in non-small cell lung carcinoma. Int. J. Oncol. 2012, 40, 2111–2121.
24. Nasim, M. T., Ogo, T., Chowdhury, H. M., Zhao, L. et al., BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH. Hum. Mol. Genet. 2012, 21, 2548–2558.
25. Xu, W., Koeck, T., Lara, A. R., Neumann, D.,et al., Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc. Natl. Acad. Sci. U S A 2007, 104, 1342–1347.
26. Wilson, J. L., Yu, J., Taylor, L., Polgar, P., Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK. PloS One 2015, 10, e0123662.
27. Veith, C., Marsh, L. M., Wygrecka, M., Rutschmann, K. et al., Paxillin regulates pulmonary arterial smooth muscle cell function in pulmonary hypertension. Am. J. Pathol. 2012, 181, 1621–1633.
28. Jones, R. J., Young, O., Renshaw, L., Jacobs, V. et al., Src inhibitors in early breast cancer: a methodology, feasibility and variability study. Breast Cancer Res. Treat. 2009, 114, 211–221.
29. Silver, D. L., Naora, H., Liu, J., Cheng, W., Montell, D. J., Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res. 2004, 64, 3550–3558.
30. Rajeshkumar, N. V., Tan, A. C., De Oliveira, E., Womack, C. et al., Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2009, 15, 4138–4146.
31. Paulin, R., Meloche, J., Bonnet, S., STAT3 signaling in pulmonary arterial hypertension. JAKSTAT 2012, 1, 223–233.
32. Jimbo, M., Blanco, F. F., Huang, Y.-H., Telonis, A. G. et al., Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget 2015, 6, 27312–27331.
33. Zhang, P., Cao, M., Liu, Y., Lv, Z. et al., PDGF-induced airway smooth muscle proliferation is associated with Human antigen R activation and could be weakened by AMPK activation. Mol. Biol. Rep. 2012, 39, 5819–5829.
34. de Frutos, S., Nitta, C. H., Caldwell, E., Friedman, J. et al., Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297, L475–L486.